Sixty seconds on . . . TamifluBMJ 2016; 353 doi: https://doi.org/10.1136/bmj.i3064 (Published 01 June 2016) Cite this as: BMJ 2016;353:i3064
- Nigel Hawkes
Oh dear, I feel a headache coming on: Tamiflu’s back in the news.
Yes, indeed. A new Cochrane analysis has found insufficient evidence to show that it saved lives in the 2009 H1N1 flu epidemic.1
So we wasted a ton of money, right?
The United Kingdom spent £424m (€550m; $613m) on stockpiling oseltamivir (Tamiflu). The Cochrane team says that it reduced the length of the infection in adults by 16.8 hours and in otherwise healthy children by …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial